Hexamethonium attenuates sympathetic activity and blood pressure in spontaneously hypertensive rats

Li,Peng; Gong,Jue‑Xiao; Sun,Wei; Zhou,Bin; Kong,Xiang‑Qing

doi:10.3892/mmr.2015.4315

Hexamethonium attenuates sympathetic activity and blood pressure in spontaneously hypertensive rats

Authors:
- Peng Li
- Jue‑Xiao Gong
- Wei Sun
- Bin Zhou
- Xiang‑Qing Kong
View Affiliations

Affiliations: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
Published online on: September 10, 2015 https://doi.org/10.3892/mmr.2015.4315
Pages: 7116-7122

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sympathetic activity is enhanced in heart failure and hypertensive rats. The aims of the current study were: i) To investigate the association between renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) in response to intravenous injection of the ganglionic blocker hexamethonium; and ii) to determine whether normal Wistar rats and spontaneously hypertensive rats (SHRs) differ in their response to hexamethonium. RSNA and MAP were recorded in anaesthetized rats. Intravenous injection of four doses of hexamethonium significantly reduced the RSNA, MAP and heart rate (HR) in the Wistar rats and SHRs. There were no significant differences in the RSNA, MAP or HR between Wistar rats and SHRs at the two lowest doses of hexamethonium. However, the two highest doses of hexamethonium resulted in a greater reduction in the RSNA and MAP in SHRs compared with Wistar rats. There was a significant positive correlation between the alterations in RSNA and MAP in response to the intravenous injection of hexamethonium in the Wistar rats and SHRs. There were no significant differences in the timing of the maximal effects on RSNA, MAP or HR or in recovery following hexamethonium treatment. These results suggest that there is an association between the RSNA and MAP response to intravenous injection of hexamethonium and that the alterations in MAP in response to hexamethonium may be used to evaluate basal sympathetic nerve activity.

View Figures

View References

1	Hogarth AJ, Mackintosh AF and Mary DA: The effect of gender on the sympathetic nerve hyperactivity of essential hypertension. J Hum Hypertens. 21:239–245. 2007.
2	Remuzzi G: Sympathetic overactivity in hypertensive patients with chronic renal disease. N Engl J Med. 340:1360–1361. 1999. View Article : Google Scholar : PubMed/NCBI
3	Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, Koomans HA and Blankestijn PJ: Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension. 49:506–510. 2007. View Article : Google Scholar : PubMed/NCBI
4	Xiong XQ, Chen WW, Han Y, Zhou YB, Zhang F, Gao XY and Zhu GQ: Enhanced adipose afferent reflex contributes to sympathetic activation in diet-induced obesity hypertension. Hypertension. 60:1280–1286. 2012. View Article : Google Scholar : PubMed/NCBI
5	Li P, Sun HJ, Cui BP, Zhou YB and Han Y: Angiotensin-(1–7) in the rostral ventrolateral medulla modulates enhanced cardiac sympathetic afferent reflex and sympathetic activation in reno-vascular hypertensive rats. Hypertension. 61:820–827. 2013. View Article : Google Scholar : PubMed/NCBI
6	Ye ZY, Li DP and Pan HL: Regulation of Hypothalamic Presympathetic Neurons and Sympathetic Outflow by Group II Metabotropic Glutamate Receptors in Spontaneously Hypertensive Rats. Hypertension. 62:255–262. 2013. View Article : Google Scholar : PubMed/NCBI
7	Sun HJ, Li P, Chen WW, Xiong XQ and Han Y: Angiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats. PLoS One. 7:e525572012. View Article : Google Scholar
8	Yuan N, Zhang F, Zhang LL, Gao J, Zhou YB, Han Y and Zhu GQ: SOD1 gene transfer into paraventricular nucleus attenuates hypertension and sympathetic activity in spontaneously hypertensive rats. Pflugers Arch. 465:261–270. 2013. View Article : Google Scholar
9	Fujita M, Ando K, Nagae A and Fujita T: Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension. 50:360–367. 2007. View Article : Google Scholar : PubMed/NCBI
10	Burt CC and Graham AJ: Pentamethonium and hexamethonium iodide in investigation of peripheral vascular disease and hypertension. BMJ. 1:455–460. 1950. View Article : Google Scholar : PubMed/NCBI
11	Bechgaard P, Iversen T and Nielsen AL: Hexamethonium therapy of essential hypertension. Ugeskr Laeger. 113:1335–1340. 1951.In Danish. PubMed/NCBI
12	Nunes FC and Braga VA: Chronic angiotensin II infusion modulates angiotensin II type I receptor expression in the subfornical organ and the rostral ventrolateral medulla in hypertensive rats. J Renin Angiotensin Aldosterone Syst. 12:440–445. 2011. View Article : Google Scholar : PubMed/NCBI
13	França-Silva MS, Monteiro MM, Queiroz TM, Santos AF, Athayde-Filho PF and Braga VA: The new nitric oxide donor 2-nitrate-1,3-dibuthoxypropan alters autonomic function in spontaneously hypertensive rats. Auton Neurosci. 171:28–35. 2012. View Article : Google Scholar : PubMed/NCBI
14	Touw KB, Haywood JR, Shaffer RA and Brody MJ: Contribution of the sympathetic nervous system to vascular resistance in conscious young and adult spontaneously hypertensive rats. Hypertension. 2:408–418. 1980. View Article : Google Scholar : PubMed/NCBI
15	Sato Y, Ando K and Fujita T: Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats. Hypertension. 9:81–87. 1987. View Article : Google Scholar : PubMed/NCBI
16	Guide for the Care and Use of Laboratory Animals. 6th edition. National Research Council (US) Institute for Laboratory Animal Research; Washington, DC, USA: 1996
17	Li DP and Pan HL: Role of gamma-aminobutyric acid (GABA) A and GABAB receptors in paraventricular nucleus in control of sympathetic vasomotor tone in hypertension. J Pharmacol Exp Ther. 320:615–626. 2007. View Article : Google Scholar
18	Katholi RE, Whitlow PL, Winternitz SR and Oparil S: Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension. Hypertension. 4:166–174. 1982.PubMed/NCBI
19	Rahn KH, Barenbrock M and Hausberg M: The sympathetic nervous system in the pathogenesis of hypertension. J Hypertens Suppl. 17:S11–S14. 1999.PubMed/NCBI
20	Mancia G, Grassi G, Giannattasio C and Seravalle G: Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 34:724–728. 1999. View Article : Google Scholar : PubMed/NCBI
21	Morise T, Horita M, Kitagawa I, Shinzato R, Hoshiba Y, Masuya H, Suzuki M and Takekoshi N: The potent role of increased sympathetic tone in pathogenesis of essential hypertension with neurovascular compression. J Hum Hypertens. 14:807–811. 2000. View Article : Google Scholar : PubMed/NCBI
22	Del Colle S, Morello F, Rabbia F, Milan A, Naso D, Puglisi E, Mulatero P and Veglio F: Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol. 50:487–496. 2007. View Article : Google Scholar : PubMed/NCBI
23	Fisher JP and Fadel PJ: Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension. Exp Physiol. 95:572–580. 2010. View Article : Google Scholar : PubMed/NCBI
24	Balasubramanian P, Sirivelu MP, Weiss KA, Wagner JG, Harkema JR, Morishita M, Mohankumar PS and Mohankumar SM: Differential effects of inhalation exposure to PM2.5 on hypothalamic monoamines and corticotrophin releasing hormone in lean and obese rats. Neurotoxicology. 36:106–111. 2013. View Article : Google Scholar
25	Zhou H, Sun HJ, Chang JR, Ding L, Gao Q, Tang CS, Zhu GQ and Zhou YB: Cardiac sympathetic afferent reflex response to intermedin microinjection into paraventricular nucleus is mediated by nitric oxide and γ-amino butyric acid in hypertensive rats. Exp Biol Med (Maywood). 239:1352–1359. 2014. View Article : Google Scholar
26	Zhang LL, Ding L, Zhang F, Gao R, Chen Q, Li YH, Kang YM and Zhu GQ: Salusin-β in rostral ventrolateral medulla increases sympathetic outflow and blood pressure via superoxide anions in hypertensive rats. J Hypertens. 32:1059–1067. 2014. View Article : Google Scholar
27	Maranon RO, Lima R, Mathbout M, do Carmo JM, Hall JE, Roman RJ and Reckelhoff JF: Postmenopausal hypertension: Role of the sympathetic nervous system in an animal model. Am J Physiol Regul Integr Comp Physiol. 306:R248–R256. 2014. View Article : Google Scholar : PubMed/NCBI
28	Shanks J, Manou-Stathopoulou S, Lu CJ, Li D, Paterson DJ and Herring N: Cardiac sympathetic dysfunction in the prehypertensive spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 305:H980–H986. 2013. View Article : Google Scholar : PubMed/NCBI